Status:

NOT_YET_RECRUITING

Glymphatic Function TMS Study

Lead Sponsor:

University of Arizona

Conditions:

Mild Cognitive Impairment

Eligibility:

All Genders

50-85 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to use transcranial magnetic stimulation (TMS) in older adults to impact the glymphatic system. The glymphatic system is a brain-wide clearance pathway that plays a crucia...

Eligibility Criteria

Inclusion

  • Individuals with mild cognitive impairment (MCI Group)
  • Age 18-85 years
  • MCI subjective criteria: self- or informant-reported cognitive complaint
  • Objective cognitive impairment supported by one of the following measures of general cognitive function: (a) classified as MCI via the NACC-UDS 3.0 neuropsychological battery using the typical neuropsychological criteria for MCI diagnosis (1 score on any test at least1.5 SD below the mean); or (b) classified as MCI via the NACC-UDS 3.0 neuropsychological battery using the Jak/Bondi neuropsychological criteria for MCI diagnosis(2 scores at least 1 SD below the mean in one domain, or 3 scores at least 1SD below the mean across domains)
  • Right-handed
  • English speaking
  • Able to attend daily intervention and outcome measurements for \~15 days over a 6 month period.
  • Not enrolled in another interventional study within 6 months prior to beginning this study

Exclusion

  • Contraindications to transcranial magnetic stimulation (TMS) or magnetic resonance imaging (MRI)
  • Reported sudden or steep decline of cognitive performance
  • Telephone Interview for cognitive impairment (TICS) score
  • Other neurological disorders (e.g., stroke, head injuries, or multiple sclerosis)
  • Psychiatric disorder (except stable late-life depression due to its high prevalence in MCI individuals)
  • Current cancer treatment or other comorbid/unstable medical conditions that might independently affect cognitive function

Key Trial Info

Start Date :

January 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT07192913

Start Date

January 1 2026

End Date

July 1 2026

Last Update

December 17 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Glymphatic Function TMS Study | DecenTrialz